131 related articles for article (PubMed ID: 28938189)
1. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients.
Roozbehkia M; Mahmoudi M; Aletaha S; Rezaei N; Fattahi MJ; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
Int Immunopharmacol; 2017 Nov; 52():191-196. PubMed ID: 28938189
[TBL] [Abstract][Full Text] [Related]
2. M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway.
Aletaha S; Haddad L; Roozbehkia M; Bigdeli R; Asgary V; Mahmoudi M; Mirshafiey A
Scand J Immunol; 2017 Feb; 85(2):122-129. PubMed ID: 27943385
[TBL] [Abstract][Full Text] [Related]
3. The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.
Jafarnezhad-Ansariha F; Yekaninejad MS; Jamshidi AR; Mansouri R; Vojdanian M; Mahmoudi M; Fattahi MJ; Hashemi SN; Rehm BHA; Matsuo H; Esposito E; Cuzzocrea S; Mirshafiey A
Inflammopharmacology; 2018 Apr; 26(2):375-384. PubMed ID: 28819782
[TBL] [Abstract][Full Text] [Related]
4. The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell Line.
Sharifi L; Moshiri M; Dallal MMS; Asgardoon MH; Nourizadeh M; Bokaie S; Mirshafiey A
Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):57-65. PubMed ID: 30539708
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial.
Fattahi MJ; Jamshidi AR; Mahmoudi M; Vojdanian M; Yekaninejad MS; Jafarnezhad-Ansariha F; Ahmadi H; Rehm BHA; Matsuo H; Cuzzocrea S; Hosseini M; Hashemi SN; Aghazadeh Z; Mirshafiey A
Int Immunopharmacol; 2018 Jan; 54():112-117. PubMed ID: 29127910
[TBL] [Abstract][Full Text] [Related]
6. Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis.
Fattahi MJ; Ahmadi H; Jafarnezhad-Ansariha F; Mortazavi-Jahromi SS; Rehm BHA; Cuzzocrea S; Matsuo H; Mirshafiey A
Biomed Pharmacother; 2018 Apr; 100():495-500. PubMed ID: 29477913
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of β-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-κB gene expression, as target molecules in inflammatory reactions.
Mortazavi-Jahromi SS; Jamshidi MM; Farazmand A; Aghazadeh Z; Yousefi M; Mirshafiey A
Pharmacol Rep; 2017 Jun; 69(3):479-484. PubMed ID: 28324845
[TBL] [Abstract][Full Text] [Related]
8. The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients.
Gaafar NAG; Aslani M; Aghazadeh Z; Razavi A; Mirshafiey A
Curr Drug Discov Technol; 2020; 17(5):704-710. PubMed ID: 31250758
[TBL] [Abstract][Full Text] [Related]
9. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
Mortazavi-Jahromi SS; Ahmadzadeh A; Rezaieyazdi Z; Aslani M; Omidian S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):228-236. PubMed ID: 32223462
[No Abstract] [Full Text] [Related]
10. Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC.
Khalatbari A; Mahdavi M; Jafarnezhad F; Afraei S; Zavareh FT; Aghazadeh Z; Ghaderi A; Mirshafiey A
Curr Drug Discov Technol; 2020; 17(2):225-232. PubMed ID: 30417790
[TBL] [Abstract][Full Text] [Related]
11. Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients.
Mortazavi-Jahromi SS; Aslani M; Omidian S; Ahmadzadeh A; Rezaieyazdi Z; Mirshafiey A
Drug Dev Res; 2020 May; 81(3):295-304. PubMed ID: 31675124
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Mannuronic Acid Effect on Gene Expression Profile of Inflammatory Mediators in Rheumatoid Arthritis Patients.
Omidian S; Aghazadeh Z; Ahmadzadeh A; Aslani M; Hosseini M; Abbasi S; Mirshafiey A
Iran J Allergy Asthma Immunol; 2022 Feb; 21(1):44-54. PubMed ID: 35524377
[TBL] [Abstract][Full Text] [Related]
13. Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property.
Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Vojdanian M; Fattahi MJ; Rastkari N; Aghazadeh Z; Mirshafiey A
Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):433-442. PubMed ID: 29149783
[TBL] [Abstract][Full Text] [Related]
14. Modification of Sexual Hormones in Rheumatoid Arthritis Patients by M2000 (β-D-mannuronic Acid) as a Novel NSAID with Immunosuppressive Property.
Jahanbakhshi M; Babaloo Z; Mortazavi-Jahromi SS; Shokri MM; Ahmadi H; Mirshafiey A
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):530-536. PubMed ID: 29667557
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression.
Noman AS; Koide N; Hassan F; I-E-Khuda I; Dagvadorj J; Tumurkhuu G; Islam S; Naiki Y; Yoshida T; Yokochi T
Innate Immun; 2009 Feb; 15(1):33-41. PubMed ID: 19201823
[TBL] [Abstract][Full Text] [Related]
16. Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes.
Campo GM; Avenoso A; Campo S; D'Ascola A; Nastasi G; Calatroni A
Biochimie; 2010 Feb; 92(2):204-15. PubMed ID: 19879319
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cell adhesion molecules (LFA-1 and L-selectin) in ankylosing spondylitis patients after treatment with β-D-mannuronic acid (M2000).
Fattahi MJ; A Rehm BH; Matsuo H; Cuzzocrea S; Jafarnezhad-Ansariha F; Ahmadi H; Tofighi-Zavareh F; Oraei M; Aghazadeh Z; Mirshafiey A
Indian J Med Res; 2023 May; 157(5):453-459. PubMed ID: 37955219
[TBL] [Abstract][Full Text] [Related]
18. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis.
Ahmadi H; Jamshidi AR; Mahmoudi M; Cuzzocrea S; Fattahi MJ; Barati A; Rehm BHA; Matsuo H; Mirshafiey A
Curr Drug Discov Technol; 2017; 14(3):206-214. PubMed ID: 28325148
[TBL] [Abstract][Full Text] [Related]
19. Asarinin inhibits immunological rejection via the Toll-like receptor-myeloid differentiation factor 88 signaling pathway in vitro.
Zhang L; Sun Y; Yang Z; Xia P
Transpl Immunol; 2023 Dec; 81():101949. PubMed ID: 37918581
[TBL] [Abstract][Full Text] [Related]
20. Female sex hormones modulate Porphyromonas gingivalis lipopolysaccharide-induced Toll-like receptor signaling in primary human monocytes.
Jitprasertwong P; Charadram N; Kumphune S; Pongcharoen S; Sirisinha S
J Periodontal Res; 2016 Jun; 51(3):395-406. PubMed ID: 26364725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
